Immatics N.V.

NASDAQ:IMTX

Biotechnology

Healthcare
$5.95 +1.58%

+$0.15 today

Market cap
$890.33M
Beta
1.30
P/E (TTM)
-5.3
EPS (TTM)
-$1.59
52W Low $5.05High $12.41

Volume 0.99M

Average 0.46M

Price history

Immatics N.V. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-42.40%

Period high

$11.87

Period low

$5.95

Latest

$5.95

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
6-KNov 10, 2026Nov 10, 2026
6-KOct 26, 2026Oct 26, 2026
6-KOct 23, 2026Oct 23, 2026
SC 13D/AAug 27, 2026Aug 27, 2026
4Aug 27, 2026Aug 27, 2026
6-KAug 26, 2026Aug 26, 2026
424B2Aug 25, 2026Aug 25, 2026
6-KAug 18, 2026Aug 18, 2026
4Aug 18, 2026Aug 18, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
3Jul 29, 2026Jul 29, 2026
S-8Jun 25, 2026Jun 25, 2026
4Jun 18, 2026Jun 18, 2026
4Jun 18, 2026Jun 18, 2026

Competitors

Who does Immatics N.V. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IMTX's filings, answered from its disclosures.

What is the latest IMTX filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does IMTX have?

Intrinsic Alpha currently shows 20 recent filings for IMTX.